20-59301185-G-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_207034.3(EDN3):​c.53-225G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 152,290 control chromosomes in the GnomAD database, including 1,988 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.14 ( 1988 hom., cov: 33)

Consequence

EDN3
NM_207034.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.282

Publications

2 publications found
Variant links:
Genes affected
EDN3 (HGNC:3178): (endothelin 3) The protein encoded by this gene is a member of the endothelin family. Endothelins are endothelium-derived vasoactive peptides involved in a variety of biological functions. The active form of this protein is a 21 amino acid peptide processed from the precursor protein. The active peptide is a ligand for endothelin receptor type B (EDNRB). The interaction of this endothelin with EDNRB is essential for development of neural crest-derived cell lineages, such as melanocytes and enteric neurons. Mutations in this gene and EDNRB have been associated with Hirschsprung disease (HSCR) and Waardenburg syndrome (WS), which are congenital disorders involving neural crest-derived cells. Altered expression of this gene is implicated in tumorigenesis. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
EDN3 Gene-Disease associations (from GenCC):
  • Waardenburg syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Waardenburg syndrome type 4B
    Inheritance: AR, AD, SD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, PanelApp Australia, G2P
  • Waardenburg-Shah syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease, susceptibility to, 4
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 20-59301185-G-T is Benign according to our data. Variant chr20-59301185-G-T is described in ClinVar as [Benign]. Clinvar id is 1178568.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.258 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EDN3NM_207034.3 linkc.53-225G>T intron_variant Intron 1 of 4 ENST00000337938.7 NP_996917.1 P14138-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EDN3ENST00000337938.7 linkc.53-225G>T intron_variant Intron 1 of 4 1 NM_207034.3 ENSP00000337128.2 P14138-1

Frequencies

GnomAD3 genomes
AF:
0.137
AC:
20848
AN:
152172
Hom.:
1966
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.261
Gnomad AMI
AF:
0.200
Gnomad AMR
AF:
0.0793
Gnomad ASJ
AF:
0.0933
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.114
Gnomad FIN
AF:
0.0815
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.0963
Gnomad OTH
AF:
0.136
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.137
AC:
20920
AN:
152290
Hom.:
1988
Cov.:
33
AF XY:
0.134
AC XY:
9959
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.262
AC:
10883
AN:
41530
American (AMR)
AF:
0.0792
AC:
1212
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0933
AC:
324
AN:
3472
East Asian (EAS)
AF:
0.00154
AC:
8
AN:
5188
South Asian (SAS)
AF:
0.115
AC:
554
AN:
4830
European-Finnish (FIN)
AF:
0.0815
AC:
865
AN:
10614
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.0963
AC:
6552
AN:
68030
Other (OTH)
AF:
0.135
AC:
285
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
897
1794
2690
3587
4484
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.106
Hom.:
600
Bravo
AF:
0.141
Asia WGS
AF:
0.0700
AC:
242
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.4
DANN
Benign
0.68
PhyloP100
0.28
PromoterAI
0.028
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149214; hg19: chr20-57876240; API